Sodium fluoride

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 2 years and older, a small, pea-sized amount of MI Paste ONE Kids should be applied to the toothbrush. It is recommended to brush for a duration of 2 minutes, followed by expectoration. Patients should avoid eating or drinking for 30 minutes after brushing to achieve optimal results. This product should be used twice daily.

After each use, it is important to securely replace the cap to maintain product integrity. For children under 2 years of age, consultation with a dentist or physician is advised prior to use.

Contraindications

Use is contraindicated in patients with a known allergy to milk protein or hydroxybenzoates. Due to the potential for severe allergic reactions, administration in these individuals is not recommended.

Warnings and Precautions

It is imperative to keep this product out of reach of children under 6 years of age to prevent accidental ingestion and potential harm.

In the event that more than the recommended amount of paste is accidentally swallowed, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

This product is contraindicated in patients with known allergies to milk proteins or hydroxybenzoates. Healthcare professionals should ensure that patients are screened for these allergies prior to use.

Should an allergic reaction occur, it is essential to discontinue use immediately. The affected individual should rinse their mouth thoroughly with water and seek medical advice to address the reaction appropriately.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is crucial to keep the product out of reach of children under 6 years of age. In the event that more than the recommended amount of paste is accidentally swallowed, medical assistance should be sought immediately, or contact a Poison Control Center.

The product is contraindicated in patients with known allergies to milk proteins or hydroxybenzoates. Should an allergic reaction occur, it is advised to discontinue use, rinse the mouth with water, and seek medical advice promptly.

These precautions are essential to ensure the safety and well-being of patients using this product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mipaste One Kids Blue Raspberry. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

For pediatric patients aged 2 years and older, a small, pea-size amount of MI Paste ONE Kids should be applied to the toothbrush. In children under 2 years of age, it is advised to consult a dentist or physician prior to use.

Caution is warranted as MI Paste ONE Kids should be kept out of reach of children under 6 years of age. In the event that more than the recommended amount of paste is accidentally swallowed, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted clinical data in this population.

Pregnancy

The safety of MI Paste One Kids Blue Raspberry during pregnancy has not been established. While there are no specific contraindications for use in pregnant patients, caution is advised. Currently, there is no specific information available regarding the risk to the fetus associated with the use of this product. Additionally, no dosage modifications for pregnant individuals are mentioned. It is recommended that women of childbearing potential consult a healthcare provider before using MI Paste One Kids Blue Raspberry during pregnancy to ensure appropriate guidance and care.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers. The safety of this product during lactation has not been established.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If an individual accidentally swallows more than the recommended amount of the paste, it is imperative to seek medical help or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt intervention can mitigate potential adverse effects associated with overdosage. Monitoring the patient for any symptoms that may arise is essential, although specific symptoms related to overdosage are not detailed in the available data.

Management of overdosage should focus on supportive care and symptomatic treatment as necessary. It is advisable to follow established protocols for the management of overdose cases, ensuring that the patient receives appropriate evaluation and treatment based on their clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: allergic reactions, which include manifestations such as rash, itching, and swelling.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. Instruct patients that if more than the recommended amount of paste is accidentally swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients not to use this product if they have a known allergy to milk protein or hydroxybenzoates. In the event of an allergic reaction, patients should be instructed to stop using the product, rinse their mouth with water, and seek medical advice promptly.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers. It should be stored at room temperature to maintain its integrity and effectiveness. After each use, it is essential to replace the cap to prevent contamination. Additionally, the product must be discarded after opening to ensure safety and compliance with handling guidelines.

Additional Clinical Information

For patients aged 2 years and older, MI Paste ONE Kids should be administered via the dental route. A small, pea-sized amount is to be applied to the toothbrush, with a recommended brushing duration of 2 minutes. After brushing, patients should expectorate and refrain from eating or drinking for 30 minutes. This application is advised twice daily.

Clinicians should counsel patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the recommended amount, immediate medical assistance or contact with a Poison Control Center is necessary. The product is contraindicated in individuals with allergies to milk protein or hydroxybenzoates. Should an allergic reaction occur, patients are advised to discontinue use, rinse their mouth with water, and seek medical advice.

Drug Information (PDF)

This file contains official product information for Mipaste One Kids Blue Raspberry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)